(Q37853607)

24 August 2017

1 reference

title

Cutaneous community-acquired and hospital-acquired methicillin-resistant Staphylococcus aureus (English)

1 reference

methicillin-resistant Staphylococcus aureus

24 August 2017

main subject

0 references

Staphylococcus aureus

1 reference

Nina Kaur Hansra

1

1 reference

24 August 2017

Kanade Shinkai

series ordinal

2

1 reference

24 August 2017

publication date

1 March 2011

1 reference

24 August 2017

1 reference

24 August 2017

volume

24

1 reference

24 August 2017

issue

2

1 reference

24 August 2017

page(s)

263-272

1 reference

Methicillin-resistant Staphylococcus aureus disease in three communities

24 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Community-acquired methicillin resistant Staphylococcus aureus skin infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Nasal carriage of Staphylococcus aureus and methicillin-resistant S aureus in the United States, 2001-2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Excess costs and utilization associated with methicillin resistance for patients with Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Community-acquired methicillin-resistant Staphylococcus aureus skin infections: implications for patients and practitioners

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Early appropriate parenteral antimicrobial treatment of complicated skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Community-associated meticillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

The skin in the gym: a comprehensive review of the cutaneous manifestations of community-acquired methicillin-resistant Staphylococcus aureus infection in athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Community-acquired methicillin-resistant Staphylococcus aureus skin infection: an emerging clinical problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Community-acquired methicillin-resistant Staphylococcus aureus skin infection: a retrospective analysis of clinical presentation and treatment of a local outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Purpura fulminans due to Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Microbiologic evaluation of cutaneous cellulitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Surveillance cultures for detection of methicillin-resistant Staphylococcus aureus: diagnostic yield of anatomic sites and comparison of provider- and patient-collected samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

How to handle a CA-MRSA outbreak

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin resistance matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Practice guidelines for the diagnosis and management of skin and soft-tissue infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Methicillin-resistant Staphylococcus aureus and athletes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Randomized controlled trial of trimethoprim-sulfamethoxazole for uncomplicated skin abscesses in patients at risk for community-associated methicillin-resistant Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Clinical practice. Skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Community-acquired methicillin-resistant Staphylococcus aureus skin infections: a review of epidemiology, clinical features, management, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Treatment options for uncomplicated community-acquired skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: oral antimicrobial agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Doxycycline, not minocycline, induces its own resistance in multidrug-resistant, community-associated methicillin-resistant Staphylococcus aureus clone USA300.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Agents for the decolonization of methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Maculopapular rash induced by oral vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

A morbilliform variant of vancomycin-induced linear IgA bullous dermatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Resistance to linezolid is mediated by the cfr gene in the first report of an outbreak of linezolid-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Daptomycin versus other antimicrobial agents for the treatment of skin and soft tissue infections: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Characterisation of a Staphylococcus aureus strain with progressive loss of susceptibility to vancomycin and daptomycin during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

New treatments for methicillin-resistant Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Treatment of methicillin-resistant staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy. For the Synercid Emergency-Use Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

The efficacy and safety of tigecycline in the treatment of skin and skin-structure infections: results of 2 double-blind phase 3 comparison studies with vancomycin-aztreonam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

The pharmacokinetic and pharmacodynamic profile of tigecycline

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Antimicrobial drugs for treating methicillin-resistant Staphylococcus aureus colonization

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Methicillin-sensitive and methicillin-resistant Staphylococcus aureus: management principles and selection of antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Reflection paper on MRSA in food-producing and companion animals: epidemiology and control options for human and animal health.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Management of cutaneous lesions associated with an emerging epidemic: community-acquired methicillin-resistant Staphylococcus aureus skin infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

Treatment of Staphylococcus aureus colonization in atopic dermatitis decreases disease severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1529-8019.2011.01402.X

10.1111/J.1529-8019.2011.01402.X

21 January 2018

Identifiers

DOI

1 reference

24 August 2017

1 reference